Transcranial Magnetic Stimulation (TMS) emerges as a safe and non-invasive therapy, well-received by individuals seeking alternative treatments. Recognized by the FDA for the treatment of unipolar depression after one unsuccessful therapy attempt, TMS demonstrates its efficacy in modifying the activity of brain regions affected by specific psychiatric diseases. Notably, TMS offers a promising avenue for addressing perinatal depression, presenting a safe and effective modality with a favorable side effect profile. This underscores the potential of TMS as a versatile and valuable therapeutic option in the realm of mental health.
top of page
bottom of page